SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Quintana, Francisco J.
Text and Data Mining valid from 2020-12-01
Version of Record valid from 2020-12-01
1 December 2020
F.J.Q. is a member of the Scientific Advisory Board of Kyn Therapeutics.
Free to read:
This content has been made available to all.